CLINICAL LABORATORY MOLECULAR DIAGNOSTICS FOR INFECTIOUS DISEASE MARKETS: Strategies and Trends, Forecasts by Application and Country with Market Analysis & Executive Guides 2023 to 2027

For the last 50+ years the clinical laboratory has undergone a process of increasing centralization. Laboratories have focussed on consolidating staff and equipment in centralized facilities designed to lower the marginal cost of an individual assay. There has been a further emphasis on reducing laboratory costs by avoiding unnecessary testing. It is our opinion that this trend (or mindset) has reached its peak and that increasingly clinical laboratory testing will:

• Become more decentralized
• Be increasingly concerned with time to result/accuracy than cost
• Increasingly become multiplex

While these trends affect all kinds of laboratory testing they are moving faster and more decisively in the area of infectious disease testing. This is being driven by Nucleic Acid based testing ie. gene sequencing and probing, notably PCR based. We expect these types of infectious disease assays to displace all other current practice.